TrialFrontiers in immunology2025

R21/Matrix-M malaria vaccine drives diverse immune responses in pre-exposed adults: insights from a phase IIb controlled human malaria infection trial.

Elizabeth Kibwana et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.